Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2113 to 2119 of 2119 entries
Sorted by: Best Match Show Resources per page
Predicting long-term cardiometabolic risk: Do childhood metabolomic signatures hold the key?.

EBioMedicine

Robinson GA, Pineda-Torra I, Ciurtin C, Jury EC.
PMID: 34800900
EBioMedicine. 2021 Nov 17;74:103702. doi: 10.1016/j.ebiom.2021.103702. Epub 2021 Nov 17.

No abstract available.

Cite
Robinson GA, Pineda-Torra I, Ciurtin C, et al. Predicting long-term cardiometabolic risk: Do childhood metabolomic signatures hold the key?. EBioMedicine. 2021;74:103702doi: 10.1016/j.ebiom.2021.103702.
Robinson, G. A., Pineda-Torra, I., Ciurtin, C., & Jury, E. C. (2021). Predicting long-term cardiometabolic risk: Do childhood metabolomic signatures hold the key?. EBioMedicine, 74103702. https://doi.org/10.1016/j.ebiom.2021.103702
Robinson, George A, et al. "Predicting long-term cardiometabolic risk: Do childhood metabolomic signatures hold the key?." EBioMedicine vol. 74 (2021): 103702. doi: https://doi.org/10.1016/j.ebiom.2021.103702
Robinson GA, Pineda-Torra I, Ciurtin C, Jury EC. Predicting long-term cardiometabolic risk: Do childhood metabolomic signatures hold the key?. EBioMedicine. 2021 Nov 17;74:103702. doi: 10.1016/j.ebiom.2021.103702. Epub 2021 Nov 17. PMID: 34800900; PMCID: PMC8605378.
Copy Download .nbib Format: NLM
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.

Pharmaceuticals (Basel, Switzerland)

Dart CR, Mukherjee N, Amato CM, Goulding A, MacBeth M, Van Gulick R, Couts KL, Lambert JR, Norris DA, Robinson WA, Shellman YG.
PMID: 34451846
Pharmaceuticals (Basel). 2021 Jul 30;14(8). doi: 10.3390/ph14080749.

Although treatment options for melanoma patients have expanded in recent years with the approval of immunotherapy and targeted therapy, there is still an unmet need for new treatment options for patients that are ineligible for, or resistant to these...

Cite
Dart CR, Mukherjee N, Amato CM, et al. A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine. Pharmaceuticals (Basel). 2021;14(8)doi: 10.3390/ph14080749.
Dart, C. R., Mukherjee, N., Amato, C. M., Goulding, A., MacBeth, M., Van Gulick, R., Couts, K. L., Lambert, J. R., Norris, D. A., Robinson, W. A., & Shellman, Y. G. (2021). A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine. Pharmaceuticals (Basel, Switzerland), 14(8), . https://doi.org/10.3390/ph14080749
Dart, Chiara R, et al. "A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine." Pharmaceuticals (Basel, Switzerland) vol. 14,8 (2021). doi: https://doi.org/10.3390/ph14080749
Dart CR, Mukherjee N, Amato CM, Goulding A, MacBeth M, Van Gulick R, Couts KL, Lambert JR, Norris DA, Robinson WA, Shellman YG. A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine. Pharmaceuticals (Basel). 2021 Jul 30;14(8). doi: 10.3390/ph14080749. PMID: 34451846; PMCID: PMC8399604.
Copy Download .nbib Format: NLM
Cortical depth-dependent modeling of visual hemodynamic responses.

Journal of theoretical biology

Lacy TC, Robinson PA, Aquino KM, Pang JC.
PMID: 34952032
J Theor Biol. 2021 Dec 21;535:110978. doi: 10.1016/j.jtbi.2021.110978. Epub 2021 Dec 21.

A physiologically based three-dimensional (3D) hemodynamic model is developed to predict the experimentally observed blood oxygen level dependent (BOLD) responses versus the cortical depth induced by visual stimuli. Prior 2D approximations are relaxed in order to analyze 3D blood...

Cite
Lacy TC, Robinson PA, Aquino KM, et al. Cortical depth-dependent modeling of visual hemodynamic responses. J Theor Biol. 2021;535:110978doi: 10.1016/j.jtbi.2021.110978.
Lacy, T. C., Robinson, P. A., Aquino, K. M., & Pang, J. C. (2021). Cortical depth-dependent modeling of visual hemodynamic responses. Journal of theoretical biology, 535110978. https://doi.org/10.1016/j.jtbi.2021.110978
Lacy, Thomas C, et al. "Cortical depth-dependent modeling of visual hemodynamic responses." Journal of theoretical biology vol. 535 (2021): 110978. doi: https://doi.org/10.1016/j.jtbi.2021.110978
Lacy TC, Robinson PA, Aquino KM, Pang JC. Cortical depth-dependent modeling of visual hemodynamic responses. J Theor Biol. 2021 Dec 21;535:110978. doi: 10.1016/j.jtbi.2021.110978. Epub 2021 Dec 21. PMID: 34952032.
Copy Download .nbib Format: NLM
Evolution in Dentistry.

The Dental register

Robinson JA.
PMID: 33699730
Dent Regist. 1890 Mar;44(3):123-127.

No abstract available.

Cite
Robinson JA. Evolution in Dentistry. Dent Regist. 1890;44(3):123-127
Robinson, J. A. (1890). Evolution in Dentistry. The Dental register, 44(3), 123-127.
Robinson, J A. "Evolution in Dentistry." The Dental register vol. 44,3 (1890): 123-127.
Robinson JA. Evolution in Dentistry. Dent Regist. 1890 Mar;44(3):123-127. PMID: 33699730; PMCID: PMC6948515.
Copy Download .nbib Format: NLM
Novel Subdiaphragmatic Ligation of Left Thoracic Duct for Refractory Postoperative Left Chylothorax.

The Annals of thoracic surgery

Robinson LA, Fontaine J, El-Haddad G, Bryant S, Perez B, Toloza E, Kis B.
PMID: 33794166
Ann Thorac Surg. 2022 Jan;113(1):e29-e31. doi: 10.1016/j.athoracsur.2021.03.052. Epub 2021 Mar 29.

A postoperative chylothorax is an uncommon but problematic surgical complication in 0.5% to 4.0% of surgical cases that nevertheless still plagues every busy thoracic surgeon. Fortunately, most chylothoraces are low volume and are readily controlled by conservative measures. A...

Cite
Robinson LA, Fontaine J, El-Haddad G, et al. Novel Subdiaphragmatic Ligation of Left Thoracic Duct for Refractory Postoperative Left Chylothorax. Ann Thorac Surg. 2021;113(1):e29-e31doi: 10.1016/j.athoracsur.2021.03.052.
Robinson, L. A., Fontaine, J., El-Haddad, G., Bryant, S., Perez, B., Toloza, E., & Kis, B. (2022). Novel Subdiaphragmatic Ligation of Left Thoracic Duct for Refractory Postoperative Left Chylothorax. The Annals of thoracic surgery, 113(1), e29-e31. https://doi.org/10.1016/j.athoracsur.2021.03.052
Robinson, Lary A, et al. "Novel Subdiaphragmatic Ligation of Left Thoracic Duct for Refractory Postoperative Left Chylothorax." The Annals of thoracic surgery vol. 113,1 (2022): e29-e31. doi: https://doi.org/10.1016/j.athoracsur.2021.03.052
Robinson LA, Fontaine J, El-Haddad G, Bryant S, Perez B, Toloza E, Kis B. Novel Subdiaphragmatic Ligation of Left Thoracic Duct for Refractory Postoperative Left Chylothorax. Ann Thorac Surg. 2022 Jan;113(1):e29-e31. doi: 10.1016/j.athoracsur.2021.03.052. Epub 2021 Mar 29. PMID: 33794166.
Copy Download .nbib Format: NLM
Driving habits, cognition, and health-related quality of life in middle-aged and older adults with HIV.

Applied neuropsychology. Adult

Robinson JJ, Walker T, Hopkins C, Bradley B, McKie P, Frank JS, Pope CN, Fazeli PL, Vance DE.
PMID: 34379556
Appl Neuropsychol Adult. 2021 Aug 11;1-11. doi: 10.1080/23279095.2021.1960530. Epub 2021 Aug 11.

Cognitive impairment is known to increase with aging in people living with HIV (PLWH). Impairment in cognitive domains required for safe driving may put PLWH at risk for poor driving outcomes, decreased mobility, and health-related quality of life (HRQoL)....

Cite
Robinson JJ, Walker T, Hopkins C, et al. Driving habits, cognition, and health-related quality of life in middle-aged and older adults with HIV. Appl Neuropsychol Adult. 2021;1-11doi: 10.1080/23279095.2021.1960530.
Robinson, J. J., Walker, T., Hopkins, C., Bradley, B., McKie, P., Frank, J. S., Pope, C. N., Fazeli, P. L., & Vance, D. E. (2021). Driving habits, cognition, and health-related quality of life in middle-aged and older adults with HIV. Applied neuropsychology. Adult, 1-11. https://doi.org/10.1080/23279095.2021.1960530
Robinson, Josiah J, et al. "Driving habits, cognition, and health-related quality of life in middle-aged and older adults with HIV." Applied neuropsychology. Adult vol. (2021): 1-11. doi: https://doi.org/10.1080/23279095.2021.1960530
Robinson JJ, Walker T, Hopkins C, Bradley B, McKie P, Frank JS, Pope CN, Fazeli PL, Vance DE. Driving habits, cognition, and health-related quality of life in middle-aged and older adults with HIV. Appl Neuropsychol Adult. 2021 Aug 11;1-11. doi: 10.1080/23279095.2021.1960530. Epub 2021 Aug 11. PMID: 34379556.
Copy Download .nbib Format: NLM
Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients.

NPJ genomic medicine

Christensen KD, Schonman EF, Robinson JO, Roberts JS, Diamond PM, Lee KB, Green RC, McGuire AL.
PMID: 34429410
NPJ Genom Med. 2021 Aug 24;6(1):72. doi: 10.1038/s41525-021-00236-2.

Many expect genome sequencing (GS) to become routine in patient care and preventive medicine, but uncertainties remain about its ability to motivate participants to improve health behaviors and the psychological impact of disclosing results. In a pilot trial with...

Cite
Christensen KD, Schonman EF, Robinson JO, et al. Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients. NPJ Genom Med. 2021;6(1):72doi: 10.1038/s41525-021-00236-2.
Christensen, K. D., Schonman, E. F., Robinson, J. O., Roberts, J. S., Diamond, P. M., Lee, K. B., Green, R. C., & McGuire, A. L. (2021). Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients. NPJ genomic medicine, 6(1), 72. https://doi.org/10.1038/s41525-021-00236-2
Christensen, Kurt D, et al. "Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients." NPJ genomic medicine vol. 6,1 (2021): 72. doi: https://doi.org/10.1038/s41525-021-00236-2
Christensen KD, Schonman EF, Robinson JO, Roberts JS, Diamond PM, Lee KB, Green RC, McGuire AL. Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients. NPJ Genom Med. 2021 Aug 24;6(1):72. doi: 10.1038/s41525-021-00236-2. PMID: 34429410; PMCID: PMC8384838.
Copy Download .nbib Format: NLM
Showing 2113 to 2119 of 2119 entries